MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: BASF
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease - BASF Nutrition & Health is introducing Hepacor® in Switzerland, a product produced with proprietary technology dedicated to help patients manage Non-Alcoholic Fatty Liver Disease (NAFLD) - BASF.com
BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease

 

NewswireToday - /newswire/ - Oslo, Norway, 2019/11/26 - BASF Nutrition & Health is introducing Hepacor® in Switzerland, a product produced with proprietary technology dedicated to help patients manage Non-Alcoholic Fatty Liver Disease (NAFLD) - BASF.com. DE000BASF111

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

With the launch in Switzerland, BASF is bringing Hepacor to the first market in continental Europe.

Containing highly concentrated and purified eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), Hepacor is uniquely designed to correct the nutritional deficiency of patients with NAFLD and can address a buildup of fat in the liver, known as steatosis, in NAFLD patients[1], [2]. Hepacor will be marketed, sold and distributed as a food for special medical purposes across Switzerland through Ideogen, a Swiss pharmaceutical company with expertise in specialty care.

NAFLD is one of the most common forms of chronic liver disease worldwide. Studies have shown that NAFLD patients suffer from EPA and DHA deficiency. A clinical study has shown that Hepacor corrects this deficiency and raises the levels of these important fatty acids in the blood[3]. Increasing the levels of EPA and DHA can help to reduce the fat burden in the liver[4] by improving the liver’s ability to process excessive pre-existing fat and at the same time inhibit the creation of new fat from dietary carbohydrates[5].

With ~25% of people in Switzerland living with NAFLD[6], Hepacor can contribute to their liver health by raising the levels of EPA and DHA needed for managing this chronic liver disease.

“The launch of Hepacor in Switzerland marks a major milestone in BASF’s plans to commercialize a dedicated solution for NAFLD management globally. Together with Ideogen in Switzerland, the BASF team has undergone a rigorous process to bring Hepacor to continental Europe and address a growing concern for patients with NAFLD,” says Christoph Garbotz, Head of Commercial Management Advanced Health Solutions, BASF. “With our European production and supply chain set up successfully, we are ready to collaborate with interested partners in greater Europe.”

Hepacor is manufactured in Norway using a patented purification technology to reduce persistent organic pollutants and other substances like unwanted lipids such as cholesterol, which are naturally found in all fish oil-based products. Research on rodents has shown that one specific environmental pollutant, PCB 153, contributes to the development of NAFLD[7], [8]. Hepacor is manufactured to minimize unnecessary exposure of NAFLD patients to such unwanted components of fish oil.

Companies interested in distribution opportunities for Hepacor outside Switzerland should contact the Advanced Health Solutions, BASF, commercial team: Christoph Garbotz at christoph.garbotz[.]basf.com or Abhijit Natu at abhijit.natu[.]basf.com.

End-consumers and health care professionals that want to learn more about Hepacor in Switzerland please contact
Ideogen A.G.
Customer Care: +41 43 311 52 52

[1] Musa-Veloso K. Systematic Review and Meta-Analysis of Controlled Intervention Studies on the Effectiveness of Long-Chain Omega-3 Fatty Acids in Patients with Nonalcoholic Fatty Liver Disease. Nutr Rev. 2018, 76 æ88æ9, 581-602.
[2] Jump DB et al. Omega-3 Polyunsaturated Fatty Acids as a Treatment Strategy for Nonalcoholic Fatty Liver Disease. Pharmacol & Therapeut 2018, 181, 108-125
[3] Tobin, D. et al. Evaluation of a High Concentrate Omega-3 for Correcting the Omega-3 Fatty Acid Nutritional Deficiency in Non-Alcoholic Fatty Liver Disease (CONDIN). Nutrients 2018, 10, 1126.
[4] Musa-Veloso K. Systematic Review and Meta-Analysis of Controlled Intervention Studies on the Effectiveness of Long-Chain Omega-3 Fatty Acids in Patients with Nonalcoholic Fatty Liver Disease. Nutr Rev. 2018, 76 æ88æ9, 581-602.
[5] Jump DB et al. Omega-3 Polyunsaturated Fatty Acids as a Treatment Strategy for Nonalcoholic Fatty Liver Disease. Pharmacol & Therapeut 2018, 181, 108-125
[6] Younossi, Z. M. et al. Global Epidemiology of Nonalcoholic Fatty Liver Disease Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes. Hepatology 64, 73 84 (2016)
[7] Shi, X. et al. Metabolomic Analysis of the Effects of Polychlorinated Biphenyls in Non-alcoholic Fatty Liver Disease. Proteome Res. 2012 July 6; 11(7): 3805 3815
[8] Wahlang, B. et al. Polychlorinated Biphenyl 153 Is a Diet-dependent Obesogen Which Worsens Nonalcoholic Fatty Liver Disease In Male C57BL6/J Mice. J Nutr Biochem. 2013 September ; 24(9): 1587 1595.

About BASF’s Nutrition & Health division

BASF Nutrition & Health provides a comprehensive product and service portfolio for the human and animal nutrition, pharmaceutical, ethanol and flavor & fragrance industries. Together with our customers, we play an active role in enhancing the nutrition, health and wellbeing of consumers all over the world. Our products fulfill the highest safety, regulatory and sustainability standards. Our human nutrition solutions include vitamins and carotenoids, plant sterols, lutein and sterol esters, emulsifiers, high-concentrated omega-3 fatty acids, human milk oligosaccharide and peptides. Vitamins and carotenoids also form an important part of our animal nutrition portfolio, as do other feed additives such as trace elements, enzymes and organic acids. We provide the pharmaceutical industry with a broad range of excipients and selected large-volume active pharmaceutical ingredients such as ibuprofen and omega-3 fatty acids. Leveraging our advanced technology, we create high performance industrial enzymes for different markets, such as ethanol production. Furthermore, we offer aroma ingredients such as citral, geraniol and L-menthol. BASF Nutrition & Health operates sites in Europe, North America, South America and in Asia-Pacific.

About BASF

At BASF (basf.com), we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. The approximately 122,000 employees in the BASF Group work on contributing to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio is organized into six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of around €63 billion in 2018. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the U.S.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: BASF

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BASF Launches Hepacor in Switzerland for the Dietary Management of Non-Alcoholic Fatty Liver Disease

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Benjamin Solms-Rusch - BASF.com 
+49 621 60-55042 benjamin.rusch[.]basf.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any BASF securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From BASF / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Global Bio-based Chemicals Market is Expected to Grow At A CAGR of 16.67% by 2027 According to Inkwood Research
Global Diabetes Drugs Market Forecast 2019-2027 Reports Inkwood Research
Dysport® Now Approved in the UK for Symptomatic Treatment of Upper Limb Spasticity in Children with Cerebral Palsy
Human Microbiome Market to Reach .08 Billion by 2023, Powered by the High Growth in Over-the-Counter Probiotics Finds Frost & Sullivan
FDA Grants Priority Review to Genentech’s Risdiplam for Spinal Muscular Atrophy
Ipsen Presents New Analyses Utilizing Modern Data Mining Approaches At ISPOR Europe 2019
Global Opioids Drugs Market is Projected to Grow At a CAGR of 2.52% by 2027 Reports Inkwood Research
Global Bio-Based Chemicals Market Projected to Grow At a CAGR of 16.67% by 2027 Finds Inkwood Research
The Global Animal Nutrition Market Projected to Grow At a CAGR of 5.94% by 2027 Finds Inkwood Research
FDA Approves Genentech’s Rozlytrek (entrectinib) for People With ROS1-Positive, Metastatic Non-small Cell Lung Cancer
BTG to Invest in Chinese Medical Isotope Diagnosis and Treatment Company Chengdu New Radiomedicine Technology
Genentech Announces Positive Results for First Global Phase III Study Investigating One-dose XOFLUZA (Baloxavir Marboxil) in Children With the Flu
Debiopharm and Ipsen Extend Their Strategic Decapeptyl® (triptorelin) Partnership for Another 15 Years
GE Healthcare and World Courier Collaborate to Drive Commercialization of Cell and Gene Therapies
Nektium Pharma Commended by Frost & Sullivan for Introducing Zynamite® - A Novel Natural Extract with Ergogenic and Nootropic Properties

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)